The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway.
Svitlana Demyanets(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Gersina Rega‐Kaun(Medical University of Vienna), Walter Tschugguel(Medical University of Vienna), W. Dietrich(Medical University of Vienna), Philipp J. Hohensinner(Ludwig Boltzmann Institute for Age Research), Stefan Kastl(Medical University of Vienna), Gerald Maurer(European Society of Radiology), Stefan Pfaffenberger(Medical University of Vienna), Ezzat M. Awad(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Thomas W. Weiss(University of Vienna), Walter S. Speidl(University of Applied Sciences St Pölten), Christoph Kaun(University of Vienna), Valery N. Bochkov(University of Graz)
PubMed
January 1, 2006
Cited by 19
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877